Tektronix biotech (Tianjin) Co., Ltd. is committed to providing customized services based on phage display and nano antibody R & D platform for global customers. Tektronix biotech's R & D team has rich experience in antibody discovery, recombinant antibody development and phage library construction and screening. Our services include the production of monoclonal antibodies against humans, monkeys, rabbits, cattle, sheep, alpacas and camels using various antibody library technologies, including phage display, bacterial display and yeast display. In addition, the antibody discovery and phage platform owned by Tech bio can provide: antibody coupled drug discovery service, car candidate molecule discovery service, and related antibody sequencing and affinity determination services; Nano antibody library construction and screening services, phage library construction and screening services, antibody affinity maturation and other related services.

Scientists of Tektronix biology are committed to providing biological research methods and services to fight against cancer and various diseases. Scientists of Tektronix biology believe that the establishment of a customer service-oriented operation mode is of great significance for optimizing the drug development process and organizing teams from different research fields to carry out future drug discovery and cancer research. This long-term development goal of Tech bio encourages us to provide customers with high-quality technical services and research results.